These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37428848)

  • 1. The structure of the RBD-E77 Fab complex reveals neutralization and immune escape of SARS-CoV-2.
    Zhang Z; Li X; Xue Y; Yang B; Jia Y; Liu S; Lu D
    Acta Crystallogr D Struct Biol; 2023 Aug; 79(Pt 8):746-757. PubMed ID: 37428848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel consensus-based computational pipeline for screening of antibody therapeutics for efficacy against SARS-CoV-2 variants of concern including Omicron variant.
    Kumar N; Kaushik R; Zhang KYJ; Uversky VN; Sahu U; Sood R; Bhatia S
    Proteins; 2023 Jun; 91(6):798-806. PubMed ID: 36629264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
    Jensen JL; Sankhala RS; Dussupt V; Bai H; Hajduczki A; Lal KG; Chang WC; Martinez EJ; Peterson CE; Golub ES; Rees PA; Mendez-Rivera L; Zemil M; Kavusak E; Mayer SV; Wieczorek L; Kannan S; Doranz BJ; Davidson E; Yang ES; Zhang Y; Chen M; Choe M; Wang L; Gromowski GD; Koup RA; Michael NL; Polonis VR; Rolland M; Modjarrad K; Krebs SJ; Joyce MG
    J Virol; 2023 Jul; 97(7):e0159622. PubMed ID: 37395646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2.
    Han P; Li L; Liu S; Wang Q; Zhang D; Xu Z; Han P; Li X; Peng Q; Su C; Huang B; Li D; Zhang R; Tian M; Fu L; Gao Y; Zhao X; Liu K; Qi J; Gao GF; Wang P
    Cell; 2022 Feb; 185(4):630-640.e10. PubMed ID: 35093192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD.
    Wang X; Hu A; Chen X; Zhang Y; Yu F; Yue S; Li A; Zhang J; Pan Z; Yang Y; Lin Y; Gao L; Zhou J; Zhao J; Li F; Shi Y; Huang F; Yang X; Peng Y; Tu L; Zhang H; Zheng H; He J; Zhang H; Xu L; Huang Q; Zhu Y; Deng K; Ye L
    Signal Transduct Target Ther; 2022 Apr; 7(1):114. PubMed ID: 35383141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
    Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
    Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
    Shi J; Zheng J; Zhang X; Tai W; Odle AE; Perlman S; Du L
    Transl Res; 2022 Oct; 248():11-21. PubMed ID: 35489692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.
    Li R; Mor M; Ma B; Clark AE; Alter J; Werbner M; Lee JC; Leibel SL; Carlin AF; Dessau M; Gal-Tanamy M; Croker BA; Xiang Y; Freund NT
    Commun Biol; 2022 Aug; 5(1):789. PubMed ID: 35931732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope.
    Wang X; Chen X; Tan J; Yue S; Zhou R; Xu Y; Lin Y; Yang Y; Zhou Y; Deng K; Chen Z; Ye L; Zhu Y
    Cell Host Microbe; 2022 Jun; 30(6):887-895.e4. PubMed ID: 35436443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern.
    Parray HA; Narayanan N; Garg S; Rizvi ZA; Shrivastava T; Kushwaha S; Singh J; Murugavelu P; Anantharaj A; Mehdi F; Raj N; Singh S; Dandotiya J; Lukose A; Jamwal D; Kumar S; Chiranjivi AK; Dhyani S; Mishra N; Kumar S; Jakhar K; Sonar S; Panchal AK; Tripathy MR; Chowdhury SR; Ahmed S; Samal S; Mani S; Bhattacharyya S; Das S; Sinha S; Luthra K; Batra G; Sehgal D; Medigeshi GR; Sharma C; Awasthi A; Garg PK; Nair DT; Kumar R
    PLoS Pathog; 2022 Dec; 18(12):e1010994. PubMed ID: 36508467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination.
    Chi X; Guo Y; Zhang G; Sun H; Zhang J; Li M; Chen Z; Han J; Zhang Y; Zhang X; Fan P; Zhang Z; Wang B; Zai X; Han X; Hao M; Fang T; Xu J; Wu S; Chen Y; Fang Y; Dong Y; Sun B; Zhang J; Li J; Zhao G; Yu C; Zhou Q; Chen W
    Signal Transduct Target Ther; 2022 Apr; 7(1):139. PubMed ID: 35478188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor.
    Andrade SA; Batalha-Carvalho JV; Curi R; Wen FH; Covas DT; Chudzinski-Tavassi AM; Moro AM
    Front Immunol; 2022; 13():871874. PubMed ID: 35898497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H.
    Zeng C; Evans JP; Faraone JN; Qu P; Zheng YM; Saif L; Oltz EM; Lozanski G; Gumina RJ; Liu SL
    mBio; 2021 Oct; 12(5):e0251021. PubMed ID: 34607452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
    Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
    Front Immunol; 2021; 12():691715. PubMed ID: 34149735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge.
    Liu Q; Zhao H; Li Z; Zhang Z; Huang R; Gu M; Zhuang K; Xiong Q; Chen X; Yu W; Qian S; Zhang Y; Tan X; Zhang M; Yu F; Guo M; Huang Z; Wang X; Xiang W; Wu B; Mei F; Cai K; Zhou L; Zhou L; Wu Y; Yan H; Cao S; Lan K; Chen Y
    Signal Transduct Target Ther; 2023 Sep; 8(1):347. PubMed ID: 37704615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants.
    Makdasi E; Zvi A; Alcalay R; Noy-Porat T; Peretz E; Mechaly A; Levy Y; Epstein E; Chitlaru T; Tennenhouse A; Aftalion M; Gur D; Paran N; Tamir H; Zimhony O; Weiss S; Mandelboim M; Mendelson E; Zuckerman N; Nemet I; Kliker L; Yitzhaki S; Shapira SC; Israely T; Fleishman SJ; Mazor O; Rosenfeld R
    Cell Rep; 2021 Sep; 36(10):109679. PubMed ID: 34464610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.